"10.1371_journal.pone.0019601","plos one","2011-05-05T00:00:00Z","Silvia Querings; Janine Altmüller; Sascha Ansén; Thomas Zander; Danila Seidel; Franziska Gabler; Martin Peifer; Eva Markert; Kathryn Stemshorn; Bernd Timmermann; Beate Saal; Stefan Klose; Karen Ernestus; Matthias Scheffler; Walburga Engel-Riedel; Erich Stoelben; Elisabeth Brambilla; Jürgen Wolf; Peter Nürnberg; Roman K Thomas","Max Planck Institute for Neurological Research with Klaus-Joachim-Zülch Laboratories of the Max Planck Society and the Medical Faculty of the University of Cologne, Cologne, Germany; Laboratory of Translational Cancer Genomics, Center of Integrated Oncology Köln Bonn, University of Cologne, Cologne, Germany; Cologne Center for Genomics, University of Cologne, Cologne, Germany; Department I for Internal Medicine and Center of Integrated Oncology Köln-Bonn, University Hospital of Cologne, Cologne, Germany; Institute for Pathology, Hospital Merheim, Cologne, Germany; Max Planck Institute for Molecular Genetics, Berlin, Germany; Pneumologische Gemeinschaftspraxis Dr. H.-P. Wagner-Dr. St. Klose-Dr. A. Kratzsch, Chemnitz, Germany; Department of Medical Oncology, Lung Clinic Merheim, Cologne, Germany; Department of Thoracic Surgery, Lung Clinic Merheim, Cologne, Germany; Department of Pathology, Institut Albert Bonniot, INSERM U823, University Joseph Fourier, CHU Grenoble Hôpital Michallon, Grenoble, France","Conceived and designed the experiments: SQ JA SA TZ BT JW PN RKT. Performed the experiments: SQ JA DS FG KS BS. Analyzed the data: SQ JA SA TZ MP MS EB JW PN RKT. Contributed reagents/materials/analysis tools: EM SK KE WER ES. Wrote the paper: SQ SA TZ RKT.","Roman K. Thomas received research support from AstraZeneca and received lecture or consultancy fees from Roche, Boehringer Ingelheim, Johnson&Johnson, AstraZeneca, Lilly, Merck, Atlas Biolabs and Sanofi-Aventis. Jürgen Wolf received research support and served as a consultant to Roche and AstraZeneca. Research support mentioned in this section was not used for conducting this study. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2011","05","Silvia Querings","SQ",20,TRUE,8,6,10,4,TRUE,TRUE,FALSE,0,NA,FALSE
